Success Metrics

Completion Rate
0%(0/1)
Active Trials
5(83%)
Terminated
1(17%)

Phase Distribution

Ph phase_1
1
17%
Ph phase_2
1
17%
Ph not_applicable
3
50%
Ph early_phase_1
1
17%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

5

trials recruiting

Total Trials

6

all time

Status Distribution
Active(5)
Terminated(1)

Detailed Status

Recruiting5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
5
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (16.7%)
Phase 11 (16.7%)
Phase 21 (16.7%)
N/A3 (50.0%)

Trials by Status

recruiting583%
terminated117%

Recent Activity

5 active trials
Showing 5 of 6
recruitingnot_applicable

Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

NCT05610852
recruitingnot_applicable

HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids

NCT06692335
recruitingphase_2

Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.

NCT07394387
terminatedphase_1

Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer

NCT03237572
recruitingearly_phase_1

Prospective Multicenter Observational Study and Promotion of the Application of Focused Ultrasound in Allergic Rhinitis

NCT06272032
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05610852Not Applicable

Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

Recruiting
NCT06692335Not Applicable

HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids

Recruiting
NCT07394387Phase 2

Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.

Recruiting
NCT03237572Phase 1

Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer

Terminated
NCT06272032Early Phase 1

Prospective Multicenter Observational Study and Promotion of the Application of Focused Ultrasound in Allergic Rhinitis

Recruiting
NCT04549688Not Applicable

Active Surveillance Plus (AS+): High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate Cancer

Recruiting

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6